Neurology is the Largest Segment by Application in the Plasma Fractionation Market From 2021–2028
According to our new research study on " Plasma Fractionation Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product, Application, End User and Geography," the market size was valued at US$ 40,731.98 million by 2028 from US$ 26,575.83 million in 2021; it is estimated to grow with a CAGR of 6.3% from 2021-2028. The report highlights the trends and drivers prevailing in the plasma fractionation market.
Based on the application, the global plasma fractionation market is segmented into neurology, immunology, hematology, critical care, pulmonology, and others. In 2021, the neurology segment held the largest market share. Plasma exchange is among the treatment used in some neurological disorders. It is a highly efficient technique and can rapidly remove circulating autoantibodies and other humoral factors from the vascular system. The rising prevalence of neurological diseases and disorders is expected to drive the segment in the forecast period. For instance, as per the data published by the American Cancer Society, in January 2021, about 24,530 malignant tumors of the brain or spinal cord will be diagnosed in the US. Thus, the increasing prevalence of neurological disorders is expected to drive the segment in the forecast period.
Plasma Fractionation Market Forecast to 2028 - Global Analysis By Product (Immunoglobulin, Albumin, Coagulation Factor Concentrates, Protease Inhibitors, Other Plasma Products); Application (Neurology, Immunology, Hematology, Critical Care, Pulmonology, Other Applications); End User (Hospitals and Clinics, Clinical Research Laboratories, Academic Institutes), and Geography
Plasma Fractionation Market Growth Report - Size Outlook 2028
Download Free Sample
Bio Products Laboratory LTD, CSL Limited, Biotest AG, Sanquin, Bharat Serums and Vaccines Limited, Grifols S.A, Kedrion, SK Plasma, Plasmagen Biosciences PVT. LTD, Octapharma AG are among the several players engaged in addressing the demands for plasma fractionation market growth.
The report segments the plasma fractionation market as follows:
Based on the product, the market is segmented into immunoglobulin, albumin, coagulation factor concentrates, protease inhibitors, and others. On the basis of application, the market is segmented into neurology, immunology, hematology, critical care, pulmonology, and others. Based on the end user, the market is classified into hospitals and clinics, clinical research laboratories, and academic institutes. Based on geography, the hospital supplies market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France), Asia Pacific (China, Japan, India), the Middle East & Africa (the UAE, Saudi Arabia, and South), and South & Central America (Brazil).
Contact Us
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com